Pre-clinical work demonstrates that simultaneous blockade of PD - 1 and CTLA - 4 administered after focal irradiation eradicates orthotopic tumours and elicits memory responses, an effect mediated by IFN-γ-licensed microglia and sustained CD4+ T-helper activity (65, 66). Here, RPL17 is linked to neoplasm.